Nintedanib

Nintedanib
Trade Name
Orphan Indication Malignant pleural mesothelioma
USA Market Approval USA
USA Designation Date 2016-12-12 00:00:00
Sponsor Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, P. O. Box 368;Ridgefield, Connecticut, 06877